Log in or Sign up for Free to view tailored content for your specialty!
Chronic Hepatitis News
Combination ravidasvir, sofosbuvir effectively treats chronic hepatitis C
Ravidasvir in addition to sofosbuvir was safe and effective in the treatment of patients with chronic hepatitis C virus, according to research published in The Lancet Gastroenterology and Hepatology.
Outreach modality linked to HCV screening rates
More patients underwent hepatitis C virus screening when there was a reduced effort in attaining a laboratory order compared with patients who had to request screening on their own, according to research published in BMJ.
Log in or Sign up for Free to view tailored content for your specialty!
9 stories for Hepatitis Awareness Month
May is Hepatitis Awareness Month in the United States, and May 19 is Hepatitis Testing Day.
Volume on consults for alcohol-related GI, liver diseases remain elevated throughout COVID-19
Despite ongoing COVID-19 infection control restrictions, volumes of inpatient consults for alcohol-related gastrointestinal and liver diseases had significantly decreased at the onset of the COVID-19 pandemic, but quickly returned to normal levels, according to an expert presentation during a press conference in advance of Digestive Diseases Week.
One-time universal screening for hepatitis B could save 23K lives, nearly $600 million
A one-time, universal screening for chronic hepatitis B infection could prevent 23,000 additional deaths from chronic HBV-related liver disease and save almost $600 million, according to a study in Clinical Infectious Diseases.
First patient dosed in a phase 2 combined therapy trial for chronic HBV
Brii Biosciences, Vir Biotechnology and VBI Vaccines announced the first patient dosed in a phase 2 trial evaluating combination therapy for the treatment of patients with chronic hepatitis B infection, according to a press release.
HBV antiviral treatment linked with reduced cirrhosis risk
Patients with chronic hepatitis B who received antiviral therapy experienced a significant reduction in risk for cirrhosis, according to study results.
Gilead, Vir partner for HBV combination research
Gilead Sciences and Vir Biotechnology will collaborate on a study to research novel combination therapies for patients with chronic hepatitis B virus, according to a Gilead press release.
Mailed outreach, inreach effective for HCV screening
A combination of inreach and mailed outreach was an effective hepatitis C screening strategy among hard-to-reach populations, according to study results.
EMR system for HCV screening in ED may be beneficial
Nearly two-thirds of patients with chronic hepatitis C infection identified via risk-based screening in the ED attended a first appointment with a provider, researchers reported at The Liver Meeting Digital Experience.
-
Headline News
‘We have a home’: Physician aims to create network of women allergists
November 14, 20245 min read -
Headline News
Diversified portfolios allow for ‘smoother ride’
November 14, 20243 min read -
Headline News
Predelivery concussion linked to increased risk for severe maternal mental illness
November 12, 20242 min read
-
Headline News
‘We have a home’: Physician aims to create network of women allergists
November 14, 20245 min read -
Headline News
Diversified portfolios allow for ‘smoother ride’
November 14, 20243 min read -
Headline News
Predelivery concussion linked to increased risk for severe maternal mental illness
November 12, 20242 min read